Anchyra Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$202K Buy
+4,635
New +$215K 0.04% 374
2026
Q2
– Sell
-5,379
Closed -$338K – 357
2026
Q1
$338K Buy
5,379
+1,324
+33% +$106K 0.1% 193
2025
Q4
$387K Buy
+4,055
New +$398K 0.12% 163

Other funds holding BSX

Anchyra Partners's BSX Position: Q3 2026 in Review

Anchyra Partners opened a new position in Boston Scientific (BSX) in Q3 2026: 4,635 shares worth $202K. The stake represents 0.04% of the portfolio and ranks #374 among its holdings. This is a return to the name: Anchyra Partners previously reported a position in BSX as recently as Q1 2026.

Anchyra Partners first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $387K in Q4 2025. 1,515 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Anchyra Partners held 4,635 shares of Boston Scientific worth $202K as of Q3 2026.
  • Boston Scientific was a new Anchyra Partners position in Q3 2026.
  • Boston Scientific made up 0.04% of Anchyra Partners's portfolio in Q3 2026, its #374 holding.
  • Anchyra Partners first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Anchyra Partners's Boston Scientific position peaked at $387K in Q4 2025.
  • 1,515 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.